CRISPR Therapeutics AG
CRSP | NASDAQ
$50.90
-$0.52 (-1.01%)
Nov 2, 2026, 10:43 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -574.07M | -568.53M | -581.6M | -488.3M | -467.8M | -385.66M | -366.25M | -239.59M | -265.8M | -217.14M | -153.61M | -353.53M | -415.93M | -524.02M | -650.18M | -680.85M | -633.45M | 311.61M | 377.66M | 411.87M | 446.58M | -392.3M |
Depreciation & Amortization | 23.01M | 19.06M | 19.48M | 18.66M | 18.97M | 19.16M | 19.26M | 19.32M | 19.5M | 19.62M | 19.84M | 20.78M | 20.88M | 23.18M | 24.17M | 24.59M | 24.89M | 21.28M | 17.95M | 14.26M | 11.27M | 9.81M |
Stock-Based Compensation | 68.32M | 52.29M | 72.5M | 76.37M | 81.31M | 87.37M | 86.57M | 83.04M | 81.47M | 79.56M | 81.03M | 85.41M | 89.99M | 93.08M | 97.95M | 100.91M | 102.56M | 106.04M | 102.39M | 95.55M | 86.59M | 73.96M |
Other Working Capital | -130K | 17.17M | 49.41M | 27.42M | -11.67M | 628K | -18.73M | -14.16M | 33.45M | 25.46M | 26.66M | 20.87M | 50.79M | 56.4M | 52.25M | 48.69M | 19.52M | 24.85M | 2.93M | 8.61M | -2.23M | -8.27M |
Other Non-Cash Items | 5.23M | 95.6M | 72.73M | 65.88M | 69.13M | -27.98M | -38.62M | -28.23M | -26.49M | -21.46M | -14.05M | -9.06M | -1.32M | 5.4M | 12.47M | 16.94M | 19.36M | 18.14M | 14.11M | 10.3M | 5.39M | 3.03M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -970K | 1.63M | 71.88M | 24.89M | -26.37M | 628K | 156.27M | -23.35M | 69.57M | -20M | -193.59M | -21.23M | -36.61M | 50.66M | 19.85M | 69.96M | 42.07M | 47.33M | 26.86M | 11.82M | -404K | 18.65M |
Operating Cash Flow | -478.48M | -399.96M | -345.01M | -302.49M | -324.77M | -306.47M | -142.77M | -188.82M | -121.76M | -159.42M | -260.38M | -277.63M | -342.99M | -351.7M | -495.74M | -468.45M | -444.56M | 504.4M | 538.97M | 543.8M | 549.43M | -286.85M |
Capital Expenditures | -2.25M | -1.21M | -914K | -651K | -796K | -1.39M | -1.9M | -2.39M | -4.28M | -7.13M | -9.47M | -14.92M | -18.82M | -24.9M | -37.19M | -40.18M | -71.21M | -90.03M | -81.71M | -78.76M | -47.24M | -22.39M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -93.48M | -93.48M | -93.48M | -93.48M | n/a | n/a | n/a | -324.81M | -324.81M | -324.81M |
Purchase of Investments | -2.32B | -1.56B | -1.02B | -1.02B | -1.1B | -1.36B | -1.49B | -1.59B | -1.42B | -1.13B | -1.07B | -1.19B | -1.27B | -1.36B | -1.42B | -1.05B | -1.39B | -1.51B | -1.51B | -1.66B | -1.31B | -917.97M |
Sales Maturities Of Investments | 1.36B | 1.17B | 1.01B | 1.08B | 1.12B | 1.16B | 1.21B | 1.12B | 1.24B | 1.3B | 1.45B | 1.49B | 1.54B | 1.36B | 1.2B | 994.29M | 717.21M | 616.48M | 555.6M | 503.27M | 361.11M | 234.29M |
Other Investing Acitivies | n/a | -25M | -25M | -25M | -25M | n/a | n/a | n/a | -1M | -2.5M | -2.5M | -2.5M | 91.98M | 93.48M | 93.48M | 93.48M | n/a | n/a | n/a | 324.81M | 324.81M | 324.81M |
Investing Cash Flow | -959.17M | -422.79M | -31.81M | 36.82M | -5.55M | -202.44M | -280.48M | -467.76M | -184.81M | 159.02M | 374.65M | 280.57M | 246.68M | -26.31M | -258.66M | -91.84M | -744.48M | -982.05M | -1.04B | -1.23B | -996.11M | -706.08M |
Debt Repayment | 600M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.77M | 21.17M | 21.17M | 21.17M | 17.88M |
Common Stock Repurchased | -722K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.01M | 18.66M | 20.73M | 22.65M | 7.63M | 8.17M | 31.29M | 29.37M | 25.74M | 25.19M | n/a | n/a | 14.14M | 14.14M | 14.14M | 14.14M | n/a | n/a | n/a | 12.56M | 26.25M | 26.25M |
Financial Cash Flow | 1.6B | 1.01B | 426.03M | 326.49M | 39.36M | 36.64M | 331.98M | 354.05M | 345.96M | 363.19M | 62.66M | 26.2M | 39.76M | 33.35M | 38.59M | 42.41M | 37.51M | 35.6M | 250.95M | 657.27M | 1.16B | 1.24B |
Net Cash Flow | 162.73M | 180.9M | 49.3M | 60.83M | -290.85M | -472.24M | -91.29M | -302.17M | 39.61M | 362.95M | 177.59M | 33.61M | -52.1M | -340.23M | -711.88M | -518.13M | -1.15B | -440.93M | -244.37M | -28.64M | 713.35M | 248.15M |
Free Cash Flow | -480.73M | -401.18M | -345.93M | -303.14M | -325.57M | -307.86M | -144.68M | -191.2M | -126.04M | -166.55M | -269.85M | -292.55M | -361.81M | -376.6M | -532.93M | -508.63M | -515.77M | 414.37M | 457.27M | 465.04M | 502.19M | -309.25M |
Adj. Free Cash Flow | -549.05M | -453.46M | -418.43M | -379.51M | -406.88M | -395.23M | -231.24M | -274.24M | -207.51M | -246.11M | -350.87M | -377.97M | -451.8M | -469.68M | -630.88M | -609.54M | -618.34M | 308.32M | 354.88M | 369.49M | 415.6M | -383.2M |
Maintenance CapEx | -2.17M | -1.02M | -517K | -254K | -254K | -961K | -1.68M | -1.43M | -3.55M | -2.84M | -2.12M | -8.31M | -12.21M | -21.84M | -37.19M | -34.8M | -65.76M | -56.13M | -47.78M | -50.22M | -18.77M | -22.37M |
Growth CapEx | -74K | -191K | -397K | -397K | -542K | -425K | -219K | -957K | -738K | -4.29M | -7.35M | -6.61M | -6.61M | -3.06M | n/a | -5.38M | -5.45M | -33.9M | -33.92M | -28.55M | -28.47M | -19.31K |
Owner Earnings | -480.65M | -400.99M | -345.53M | -302.75M | -325.03M | -307.43M | -144.46M | -190.24M | -125.31M | -162.26M | -262.49M | -285.94M | -355.2M | -373.54M | -532.93M | -503.26M | -510.32M | 448.27M | 491.19M | 493.58M | 530.66M | -309.23M |
Add to Watchlist
Select watchlists to add or remove CRSP